Cancer research at the University of Birmingham has particular strengths in leukaemia and lymphoma, paediatric cancer, urological cancers, pancreatic cancer, brain tumours and cancers of the gastrointestinal tract.

The University of Birmingham is one of the leading centres in the UK for clinical trials, having a wealth of experience across a wide range of diseases, clinical settings and trial designs. The Birmingham Centre for Clinical Trials (BCCT) brings together clinical trial expertise from across the University and, in particular, the three large, well-established, UKCRC fully-registered Clinical Trials Units. The trials portfolio at the University of Birmingham is supported by a comprehensive expert infrastructure in trial methodology.

The capacity for physical activity depends critically on optimal functioning of the cardiovascular and respiratory systems.The group studies how the integration of multiple inputs that sense metabolic and mechanical perturbations e.g. blood gases, muscle metabolic milieu and contraction status, results in appropriate autonomic neural output for regulation of blood flow, blood pressure and respiration in health and disease.

Information on the Cardiovascular Translational Group: Myocardial Ischaemia Reperfusion Injury and Heart Failure Group, led by Dr Melanie Madhani, Cardiovascular Sciences, School of Clinical and Experimental Medicine, The University of Birmingham

Cardiovascular research in the University of Birmingham encompasses studies from the molecular and signalling pathways regulating behaviour of cells of the vasculature, to the functioning of the heart and vessels in animals, to the pathophysiology of heart failure, heart attacks and atrial fibrillation, to the impact of cardiovascular diseases on public health. We are developing ways to inhibit vascular thrombosis and inflammation, optimise blood flow, improve management of those with heart disease, and test the effects of large scale interventions on the region's health.